• Home
  • Biopharmaceutical Research Services
  • Multi-Omics Services
  • Support
  • /assets/images/icon/icon-email-2.png

    Email:

    info@MtoZ-Biolabs.com

    De Novo Protein Sequencing: Principles and Methods Overview

      De novo protein sequencing is a method for identifying the primary structure (amino acid sequence) of proteins without relying on genomic sequences or protein databases. This approach is essential for characterizing unknown proteins, advancing antibody drug development, conducting proteomic analyses of non-model organisms, and investigating post-translational modifications (PTMs). Traditional protein sequencing methods depend on genomic data or known protein databases for sequence alignment and identification. However, this strategy is constrained when applied to novel species, mutant proteins, or samples with intricate PTM patterns. De novo protein sequencing has become an indispensable tool, as it infers amino acid sequences directly from mass spectrometry data without requiring prior sequence information, making it particularly valuable for the discovery of unknown proteins.

       

      Principles of De Novo Protein Sequencing

      Proteins are linear biomolecules composed of amino acids linked by peptide bonds, and their functional and structural properties are dictated by their amino acid sequence. The primary objective of de novo sequencing is to reconstruct the complete amino acid sequence by analyzing the mass spectrometric data of proteins or peptides. In the absence of a reference database, this technique necessitates highly accurate mass spectrometric analysis to identify amino acid residues and determine their sequential arrangement.

       

      Typically, de novo protein sequencing is conducted using mass spectrometry, particularly tandem mass spectrometry (Tandem Mass Spectrometry, MS/MS). In MS/MS experiments, the target protein is first subjected to enzymatic digestion (commonly with trypsin, Lys-C, or Asp-N) or chemical degradation (such as Edman degradation) to generate smaller peptide fragments. These peptides are subsequently ionized within the mass spectrometer and introduced into a fragmentation chamber, where they produce fragment ions following characteristic fragmentation patterns. By analyzing these fragment ion spectra, the sequence information of the peptides can be systematically deduced.

       

      Methods and Processes of De Novo Protein Sequencing

      De novo protein sequencing typically involves the following key steps:

       

      1. Sample Preparation and Enzymatic Digestion

      After purification, the target protein is typically digested using specific proteases, such as trypsin or pepsin, to generate small peptide fragments that are suitable for further analysis.

       

      2. Mass Spectrometry Data Acquisition

      High-resolution mass spectrometry instruments (e.g., Orbitrap, TOF, FTICR-MS) are employed for both MS1 and MS2 analysis to obtain the mass information and fragmentation patterns of the peptide fragments.

       

      3. Spectral Analysis and Sequence Deduction

      Using advanced algorithmic software (e.g., PEAKS, Novor), the spectra of ion fragments are analyzed, and the amino acid sequence is deduced based on the mass differences observed between fragment ions.

       

      4. Sequence Assembly and Validation

      The sequences inferred from the peptide fragments are assembled to form the complete protein sequence, which is then compared against existing protein databases to validate the accuracy and confidence of the results.

       

      Challenges and Development Trends in De Novo Protein Sequencing

      1. Technical Challenges

      (1) Sequencing Complexity in Complex Samples: The complexity of protein mixtures complicates the analysis, particularly when proteins with high sequence similarity are present, making it difficult to distinguish and accurately identify individual proteins.

      (2) Impact of Post-translational Modifications: Certain modifications may alter fragmentation patterns, which complicates peptide sequence determination and introduces additional challenges in interpreting mass spectrometry data.

      (3) Computational Complexity of Data Analysis: High-resolution mass spectrometry generates vast datasets, requiring advanced computational algorithms to improve the accuracy of peptide sequencing and assembly.

       

      2. Future Development Trends

      (1) Higher Resolution Mass Spectrometers: Advancements in mass spectrometry are expected to improve the resolution of fragmentation spectra, thereby enhancing the accuracy of amino acid residue identification and peptide sequencing.

      (2) Artificial Intelligence-Assisted Analysis: The integration of deep learning algorithms is anticipated to improve both the accuracy and efficiency of de novo protein sequencing, enabling more precise sequence assembly.

      (3) Multi-dimensional Separation Strategies: The combination of multi-dimensional liquid chromatography (LC) and nanospray mass spectrometry (nanospray MS) holds promise for enhancing the sensitivity and detection of low-abundance proteins.

       

      In the study of non-model organisms, where genomic information is often incomplete or lacks suitable databases, de novo protein sequencing provides a direct method for identifying novel proteins and advancing research into their biological functions. Furthermore, monoclonal antibodies (mAbs) play a critical role in biotherapeutics, with their amino acid sequences directly influencing their specificity and stability. De novo sequencing can resolve the sequences of both antibody light and heavy chains, providing essential data for optimizing antibody engineering and developing biosimilar drugs. Additionally, combining de novo protein sequencing with modification-specific enrichment techniques (such as phosphoprotein enrichment or glycopeptide enrichment) allows for the identification of modification sites and patterns, aiding in the understanding of protein functionality. As technology advances, de novo protein sequencing is poised to integrate with genomics and structural biology, marking a shift toward a "database-independent" era in life sciences. MtoZ Biolabs, as a leading provider of high-quality biological mass spectrometry and multi-omics services, offers specialized de novo protein sequencing services to its clients.

       

      MtoZ Biolabs, an integrated chromatography and mass spectrometry (MS) services provider.

      Related Services

    Submit Inquiry
    Name *
    Email Address *
    Phone Number
    Inquiry Project
    Project Description *

     

    How to order?


    /assets/images/icon/icon-message.png

    Submit Inquiry

    /assets/images/icon/icon-return.png